U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06771440) titled 'Support Tool for Antibiotic Allergy DeLabeling' on Dec. 20, 2024.

Brief Summary: Antibiotic allergy labels (AAL) are reported in 7% of inpatient's charts, especially for beta-lactams (86% of AAL, i.e., prevalence of 6%). They are associated with increased length of hospital stay, and use of second-line and broad-spectrum antibiotics. Allergy workups are able to invalidate the majority of these AAL but are time-consuming and require invasive skin and provocation testing. The investigators recently evaluated, for the first time in Europa, a strictly non-invasive delabeling protocol using a questionnaire, medical file search and contac...